Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.9K Hold
275
– – ﹤0.01% 2089
2026
Q2
$7.84K Hold
275
– – ﹤0.01% 2487
2026
Q1
$4.77K Buy
+275
New +$5.2K ﹤0.01% 2321

Other funds holding CDNA

BFC Planning's CDNA Position: Q3 2026 in Review

BFC Planning held its CareDx (CDNA) position steady in Q3 2026 at 275 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2089.

BFC Planning first reported a position in CDNA in Q1 2026 and has held it in 3 quarters since. 231 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • BFC Planning held 275 shares of CareDx worth $17.9K as of Q3 2026.
  • BFC Planning left its CareDx share count unchanged in Q3 2026.
  • CareDx made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2089 holding.
  • BFC Planning first reported a position in CareDx in Q1 2026 and has held it in 3 quarters since.
  • 231 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.